| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 2 | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 0.26 | 1.44 | 0.59 | 30.23 |
| Receivables | 4.92 | 5.74 | 2.60 | 1.15 |
| Inventory | 1.49 | 2.98 | 0.95 | 1.46 |
| Other | 3.44 | 5.11 | 5.43 | 5.14 |
| 13.01 | 17.59 | 11.88 | 46.67 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 17.81 | 1.03 | 0.63 | 0.22 |
| ST’ Debt | 44.51 | 37.63 | 56.59 | 39.05 |
| Other | 0.05 | 0.36 | 0.00 | 0.08 |
| 114.80 | 60.92 | 79.59 | 56.74 |
| 10y | 5y | 3y | |
| Sales | — | — | — |
| Cash Flow | — | — | ‡‡‡ |
| Earnings | — | — | ‡‡‡ |
| Book Value | — | — | ‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.92 | 0.97 | — | — |
—
|
| ’25 | 0.50 | 1.18 | 0.43 | 0.76 |
2.87
|
| ’24 | 3.27 | 1.47 | 2.61 | 1.79 |
9.13
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (7.43) | (16.56) | — | — |
—
|
| ’25 | (7.95) | (8.64) | (6.86) | (7.22) |
(30.67)
|
| ’24 | (14.41) | (9.65) | (4.63) | (2.27) |
(30.96)
|
| ’23 | (1.48) | (4.89) | (1.55) | (0.91) |
(8.83)
|
| ’22 | (0.49) | (0.18) | (0.13) | (0.71) |
(1.52)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (7.49) | (16.88) | — | — |
—
|
| ’25 | (8.07) | (8.73) | (7.80) | (8.49) |
(33.09)
|
| ’24 | (14.41) | (9.78) | (4.68) | (2.62) |
(31.50)
|
| ’23 | (1.60) | (4.99) | (1.61) | (0.95) |
(9.16)
|
| ’22 | (0.49) | (0.18) | (0.13) | (0.71) |
(1.52)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.15) | (0.25) | — | — |
—
|
| ’25 | (0.15) | (0.26) | (0.25) | (0.15) |
(0.82)
|
| ’24 | 0.04 | 0.00 | (0.09) | (0.11) |
(0.30)
|
| ’22 | 0.19 | 0.17 | 0.07 | 0.13 |
0.56
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | ‡‡‡‡ | 9.82 | 10.19 | 2.12 | 0.90 | — | — | — |
Low Price
|
| — | — | — | — | — | ‡‡‡‡ | 10.40 | 11.55 | 56.00 | 2.76 | — | — | — |
High Price
|
| — | — | — | — | — | ‡‡‡ | 2 | 2 | 121 | 126 | — | — | — |
Employees
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 8.01 | 0.08 | 0.02 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | 16.03 | 9.13 | 2.87 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| — | — | — | — | — | — | — | 42.01% | 55.61% | (63.40%) | — | — | — |
Gross Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | 25.25 | (21.93) | (11.93) | (42.47) | — | — | — |
EBT
|
| — | — | — | — | — | ‡‡‡ | 0.00% | (136.81%) | (130.74%) | (1,481.86%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| — | ‡‡‡ | — | — | — | ‡‡‡‡‡ | 24.26 | (22.47) | (12.38) | (43.37) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| — | — | — | — | — | — | — | 1.79 | 1.33 | 1.45 | — | — | — |
Depreciation
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.67 | 0.22 | 0.05 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.56 | (0.23) | (0.30) | (0.82) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.18) | (0.37) | (0.76) | (0.58) | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | ‡‡‡ | 0.00 | (0.01) | (0.01) | (0.05) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.18) | (0.38) | (0.78) | (0.63) | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.63) | (4.81) | (1.46) | (1.58) | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 8.63 | 23.99 | 40.63 | 52.87 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| — | — | — | — | — | — | — | 132.13 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
PE Ratio
|
| — | — | — | — | — | — | — | 15.82 | 10.37 | 22.14 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| — | — | — | — | — | — | — | 18.97 | 14.88 | 43.79 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| — | — | — | — | — | — | — | (33.20) | (4.30) | (3.79) | — | — | — |
EV/FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.52) | (8.83) | (30.96) | (30.67) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | — | — | — | (0.33) | (0.54) | (2.41) | — | — | — |
Capex
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.52) | (9.16) | (31.50) | (33.09) | — | — | — |
FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.28 | (101.79) | (43.33) | (67.70) | — | — | — |
Working Cap'
|
| — | — | — | — | — | ‡‡‡‡‡ | 1.00 | 50.75 | 42.57 | 62.64 | — | — | — |
Total Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.48 | 50.49 | 41.14 | 62.05 | — | — | — |
Net Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | (14.06) | (115.44) | (59.31) | (83.29) | — | — | — |
Sh' Equity
|
| — | — | — | — | — | ‡‡‡‡‡ | 6.82% | (12.03%) | (68.16%) | (244.07%) | — | — | — |
ROA
|
| — | — | — | — | — | ‡‡‡ | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
ROIC
|
| — | — | — | — | — | ‡‡‡ | (99.74%) | 34.70% | 14.17% | 60.83% | — | — | — |
ROE
|
GCT Semiconductor (GCTS) exemplifies the post-SPAC carnage in semis, plunging from 2024 highs above $56 to depths screaming bargain—or trap—after a merger-fueled hype cycle. Revenue cratered 43% to $9.1 million amid explosive hiring and R&D burn, yielding gaping losses, negative cash flows, dilution, and a negative book value that would make even hardened chip veterans flinch. Yet, improving gross margins hint at scalability in its niche of satellite IoT and private 5G beamforming tech, setting the stage for a potential rebound if execution clicks.
Insider action cuts through the noise: a director scooped up 746,000 shares in escalating buys through late 2025, with zero sells—a rare vote of confidence in a beaten-down name, echoing pre-turnaround signals in semis like early Qualcomm. Analyst forecasts fuel the fire, projecting revenue exploding 1,341% to $41 million in 2026 and beyond, slashing EV/sales to dirt-cheap levels and implying 138-217% upside. But profitability lags in perpetual red ink, testing if this is hypergrowth or just another SPAC mirage.
In a sector prone to brutal 4-7 year cycles, U.S.-China tensions, and inventory gluts, GCTS demands cautious opportunism—scale in on revenue proof, or risk the dilution-death spiral of yesteryear’s flops. With CHIPS Act tailwinds and IoT megatrends lurking, the asymmetry tempts, but 30 years of chip busts scream: patience pays, imprudence punishes. Dive deeper for the full risk-reward dissection.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.